[Federal Register Volume 88, Number 174 (Monday, September 11, 2023)]
[Notices]
[Pages 62379-62380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19499]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-3681]


Request for Nominations of a Nonvoting Representative of the 
Interest of the Tobacco Manufacturing Industry on the Tobacco Products 
Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for a nonvoting representative of the interests of the 
tobacco manufacturing industry to serve on the Tobacco Products 
Scientific Advisory Committee (TPSAC), in the Center for Tobacco 
Products. FDA seeks to include the views of women and men, members of 
all racial and ethnic groups, and individuals with and without 
disabilities on its advisory committees and, therefore encourages 
nominations of appropriately qualified candidates from these groups. A 
nominee may either be self-nominated or nominated by an organization. 
In addition, FDA is requesting that any industry organizations 
interested in participating in the selection of a nonvoting 
representative of the interests of the tobacco manufacturing industry 
to serve on the TPSAC, notify FDA in writing. Nominations will be 
accepted for either the representative to serve on TPSAC or for the 
selection group effective with this notice.

DATES: Nomination materials for prospective candidates should be sent 
to FDA by October 11, 2023. Concurrently, any industry organization 
interested in participating in the selection of an appropriate 
nonvoting member to represent the interests of the tobacco 
manufacturing industry must send a letter stating that interest to FDA 
by October 11, 2023 (see sections I and II of this document for further 
details).

ADDRESSES: All nominations for nonvoting representatives of the 
interests of the tobacco manufacturing industry may be submitted 
electronically by accessing the FDA Advisory Committee Membership 
Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm.
    All statements of interest from industry organizations interested 
in participating in the selection process of nonvoting representatives 
of the interests of the tobacco manufacturing industry nomination 
should be sent to Serina Hunter-Thomas (see FOR FURTHER INFORMATION 
CONTACT).

FOR FURTHER INFORMATION CONTACT: Serina Hunter-Thomas, Office of 
Science, Center for Tobacco Products, Food and Drug Administration, 
Document Control Center, 10903 New Hampshire Ave., Bldg. 71, Rm. G335, 
Silver Spring, MD 20993-0002, 1-877-287-1373 (choose Option 5), email: 
[email protected].
    Information about becoming a member of an FDA advisory committee 
can also be obtained by visiting FDA's website at: https://www.fda.gov/AdvisoryCommittees/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for a 
nonvoting representative of the interests of the tobacco manufacturing 
industry on the TPSAC.

I. General Description of the Committee Duties

    The TPSAC advises the Commissioner of Food and Drugs (the 
Commissioner) or designee in discharging responsibilities related to 
the regulation of tobacco products. The TPSAC reviews and evaluates 
safety, dependence, or health issues relating to tobacco products and 
provides appropriate advice, information, and recommendations to the 
Commissioner.

[[Page 62380]]

II. Nomination Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting representative of the 
interests of the tobacco manufacturing industry. Under part 14 (21 CFR 
part 14), nominations must include a current r[eacute]sum[eacute] or 
curriculum vitae for each nominee, including current business address 
and/or home address, telephone number, and email address if available. 
Nominations must also specify the advisory committee for which the 
nominee is recommended and must acknowledge that the nominee is aware 
of the nomination unless self-nominated. The nomination should be sent 
to the FDA Advisory Committee Membership Nomination Portal (see 
ADDRESSES) within 30 days of publication of this document (see DATES). 
FDA will forward all nominations to the organizations expressing 
interest in participating in the selection process. (Persons who 
nominate themselves as nonvoting industry representatives will not 
participate in the selection process.)

III. Selection Procedure

    The Agency is also seeking names of organizations to participate in 
the selection of the nonvoting representative of the interests of the 
tobacco manufacturing industry. Any industry organization interested in 
participating in the selection of an appropriate nonvoting member to 
represent industry interests should send a letter stating that interest 
to the FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days 
of publication of this document (see DATES). Within the subsequent 30 
days, FDA will send a letter to each organization that has expressed an 
interest in participating in the selection group, attaching a complete 
list of all organizations participating in selection; and a list of all 
non-voting nominees along with their current r[eacute]sum[eacute]s. The 
letter will also state that it is the responsibility of the interested 
organizations on the selection group to confer with one another and to 
select a candidate and an alternative as backup, within 60 days after 
the receipt of the FDA letter, to serve as the nonvoting member to 
represent industry interests for the TPSAC. The interested 
organizations are not bound by the list of nominees in selecting a 
candidate. However, if no individual is selected within 60 days, the 
Commissioner will select the nonvoting member to represent industry 
interests.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. 1001 et seq.) and part 14, relating to advisory committees.

    Dated: September 6, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-19499 Filed 9-8-23; 8:45 am]
BILLING CODE 4164-01-P